Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of neurotoxicants in the pathogenesis of Alzheimer’s disease: a mechanistic insight
Fatema Yasmin Nisa, Md. Atiar Rahman, Md. Amjad Hossen, et al.
Annals of Medicine (2021) Vol. 53, Iss. 1, pp. 1479-1504
Open Access | Times Cited: 24

Showing 24 citing articles:

Gene–environment interactions in Alzheimer disease: the emerging role of epigenetics
Lucia Migliore, Fabio Coppedè
Nature Reviews Neurology (2022) Vol. 18, Iss. 11, pp. 643-660
Closed Access | Times Cited: 122
Exposure to a mixture of heavy metals induces cognitive impairment: Genes and microRNAs involved
Hai Duc Nguyen, Min‐Sun Kim
Toxicology (2022) Vol. 471, pp. 153164-153164
Closed Access | Times Cited: 56
Effects and mechanisms of bisphenols exposure on neurodegenerative diseases risk: A systemic review
Yeqing Xu, Jun Nie, Chenghao Lu, et al.
The Science of The Total Environment (2024) Vol. 919, pp. 170670-170670
Closed Access | Times Cited: 7
Protein Kinase C (PKC) in Neurological Health: Implications for Alzheimer’s Disease and Chronic Alcohol Consumption
R.S. Kaler, Shouvik Kumar Nandy, Anupam Jyoti, et al.
Brain Sciences (2024) Vol. 14, Iss. 6, pp. 554-554
Open Access | Times Cited: 7
Environmental Toxins and Alzheimer’s Disease: a Comprehensive Analysis of Pathogenic Mechanisms and Therapeutic Modulation
Rishika Dhapola, Prajjwal Sharma, Sneha Kumari, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 6, pp. 3657-3677
Closed Access | Times Cited: 12
The coherence between PSMC6 and α-ring in the 26S proteasome is associated with Alzheimer’s disease
Jing Xiong, Xinping Pang, Xianghu Song, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 16
Open Access | Times Cited: 4
Recent Insights into the Neurobiology of Alzheimer’s Disease and Advanced Treatment Strategies
Kuttiappan Anitha, Mandeep Kumar Singh, Komal Kohat, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 4
Nanomaterial-based approaches to neurotoxin neutralization in neurodegenerative diseases
Meng Cheng, Yan Dou
Nanomedicine (2025), pp. 1-13
Closed Access
Role of prolactin in the protective effect of amisulpride against 1,2-Diacetylbenzene’s neurotoxicity
Ngoc Minh-Hong Hoang, Hai Duc Nguyen, Wonhee Jo, et al.
Environmental Toxicology and Pharmacology (2024) Vol. 107, pp. 104418-104418
Closed Access | Times Cited: 2
Heavy metals toxicity on epigenetic modifications in the pathogenesis of Alzheimer's disease (AD)
Dhivya Venkatesan, Sindduja Muthukumar, Mahalaxmi Iyer, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 6
Closed Access | Times Cited: 2
Inducing Agents for Alzheimer’s Disease in Animal Models
Karishma Khan, Nasr A. Emad, Yasmin Sultana
Journal of Exploratory Research in Pharmacology (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 2
Raddeanin A isolated from Anemone raddeana Regel improves pathological and cognitive deficits of the mice model of Alzheimer's disease by targeting β-amyloidosis
Meng Han Liu, Yong Tang, Qu Li, et al.
Phytomedicine (2023) Vol. 122, pp. 155121-155121
Closed Access | Times Cited: 4
Proteomic Analysis Reveals Physiological Activities of Aβ Peptide for Alzheimer’s Disease
X. Z. Ai, Zeyu Cao, Zhaoru Ma, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8336-8336
Open Access | Times Cited: 1
The herbicides glyphosate and glufosinate and the cyanotoxin β-N-methylamino-l-alanine induce long-term motor disorders following postnatal exposure: the importance of prior asymptomatic maternal inflammatory sensitization
Asma Oummadi, Arnaud Menuet, Sarah Méresse, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 3
Computational analysis of Alzheimer's disease-associated missense SNPs to understand underlying molecular mechanisms and identify diagnostic biomarkers
Aziza Abugaliyeva, Saad Rasool
Brain Disorders (2023) Vol. 13, pp. 100110-100110
Open Access | Times Cited: 3
Network pharmacology-based prediction of efficacy and mechanism of Chongmyunggongjin-dan acting on Alzheimer’s disease
Bitna Kweon, Sumin Ryu, Dong-Uk Kim, et al.
Journal of Korean Medicine (2023) Vol. 44, Iss. 2, pp. 106-118
Open Access | Times Cited: 2
Evaluation ofLentilactobacillus parafarraginisA6-2 strain for aluminum removal and anti-inflammatory effects: implications for alleviating Al toxicity
S. Lee, Jeong‐Muk Lim, Gwang-Min Lee, et al.
Journal of Applied Microbiology (2023) Vol. 134, Iss. 12
Closed Access | Times Cited: 2
The role of massive demographic databases in intractable illnesses: Denomics for dementia
Mark M. Stecker, Morgan R. Peltier, Allison B. Reiss
AIMS Public Health (2022) Vol. 9, Iss. 3, pp. 618-629
Open Access | Times Cited: 3
Basics of Neurotoxin Induced Animal Models for Comprehending Neurodegenerative Diseases Embracing Alzheimer's Disease and Parkinson’s Disease
Soubhagyabati Sushree, Mohapatra Lucy, Mishra Deepak, et al.
International Journal of Zoological Investigations (2024) Vol. 10, Iss. 1, pp. 545-557
Open Access
The Role of Microglia and NLRP3 Inflammasome in Perioperative Neurocognitive Disorders
Jun Sun, Chuanjun Li, Xiaohong Du, et al.
(2024)
Closed Access
Neurotoxicity of N-Nitrosodimethylamine (NDMA) in Swiss albino mice and neuroprotection by nanocurcumin
Neelu Kanwar Rajawat
Materials Today Proceedings (2022) Vol. 69, pp. A30-A41
Closed Access | Times Cited: 2
Comparative modelling and prediction of mutant structures in PSEN2 protein using computational tools
Yogita M, K. Anbarasu
Journal of Pharmaceutical Negative Results (2022) Vol. 13, Iss. SO4
Open Access | Times Cited: 1
The therapeutic and diagnostic potential of amyloid β oligomers (AβOs) selective antibodies to treat Alzheimer’s disease
Kirsten L. Viola, Maíra A. Bicca, Adrian M. Bebenek, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
The therapeutic and diagnostic potential of amyloid β oligomers (AβOs) selective antibodies to treat Alzheimer’s disease
Kirsten L. Viola, Maíra A. Bicca, Adrian M. Bebenek, et al.
(2021)
Open Access
Page 1

Scroll to top